BioSpace News Archive

Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement and/or leukotriene systems are implicated, today announced it had closed its previously announced private placement, issuing an aggregate of 5,620,296 American Depositary Shares (the “ADSs”) at $1.70 per ADS for aggregate gross proceeds of approximately $9.5 million

PDC-1421, the active ingredient of ABV-1505, is being expanded into adult ADHD trials following encouraging Phase II trial results in major depressive disorder (MDD) First of six patients has been enrolled for Phase II Part I trial of ABV-1505 at the University of California, San Francisco (UCSF) Medical Center Phase II Part II trial of ABV-1505 is expected to follow Part I and be conducted at UCSF and major medical centers in Taiwan

RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the research and development of ampakines for a variety of central nervous system disorders (CNS disorders) and cannabinoids for the treatment of sleep-related breathing disorders, is pleased to announce that on March 2, 2020, the Company and the UWM Research Foundation, Inc. (“UWMRF”), an affiliate of the University of Wisconsin-

Coronavirus nCOV-2019 antigenic epitopes predicted by EpiVax computational vaccinology and epitope prediction tools to be linked with Ii-Key to generate peptide vaccines against COVID-19

The National Association of Specialty Pharmacy, a nonprofit organization representing all specialty pharmacy industry stakeholders, opened registration for its eighth Annual Meeting & Expo, to be held Sept. 14 - 17 at the Washington Marriott Wardman Park in Washington, D.C..

MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today that the Datacise Integrated Safety Explorer will make its debut at the 2020 PHUSE U.S. Connect conference in Orlando, Florida as part of the PHUSE/FDA Data Science Innovation Challenge, where, according to PHUSE, the “greatest minds in the data sciences arena come together and collaborate.”

Medidata, the global leader in creating end-to-end solutions to support the entire clinical trial process, and a Dassault Systèmes company, announced that Medpace Inc. has entered into an agreement to integrate Medidata Rave Imaging with Medpace’s imaging systems and workflow.

MedCrypt Inc., the proactive healthcare security provider, today announced Seth Carmody as the new vice president of regulatory strategy.

Qosina is the trusted supplier of enteral components for medical devices, offering over 250 off-the-shelf products including a wide selection of legacy feeding tube connectors and fittings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200304005575/en/

Inaugural awards program recognizes heroes who have made a significant impact in the lives of individuals with lung cancer